(VIANEWS) – Apollo Tactical Income Fund (AIF), SK Telecom (SKM), Eaton Vance Risk (ETJ) have the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Apollo Tactical Income Fund (AIF) 12.15 -0.04% 11.08% 2022-11-19 15:12:08
2 SK Telecom (SKM) 20.85 -0.19% 8.22% 2022-11-28 06:39:36
3 Eaton Vance Risk (ETJ) 8.49 0.59% 8.18% 2022-11-21 01:15:07
4 Nuveen California Dividend Advantage Municipal Fund (NAC) 11.13 0.72% 5.16% 2022-11-22 19:42:14
5 Gilead Sciences (GILD) 86.26 0.98% 4.2% 2022-11-28 08:58:01
6 Phibro Animal Health Corporation (PAHC) 13.98 -3.05% 3.43% 2022-11-11 09:08:06
7 Internationa Flavors & Fragrances (IFF) 101.37 0.46% 3.38% 2022-11-28 08:15:11
8 Pan American Silver Corp. (PAAS) 14.59 6.96% 2.66% 2022-11-11 08:23:16

Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Apollo Tactical Income Fund (AIF) – Dividend Yield: 11.08%

Apollo Tactical Income Fund’s last close was $12.15, 23.87% under its 52-week high of $15.96.

Apollo Tactical Income Fund Inc., a closed-ended fixed income investment fund, was launched by Apollo Credit Management, LLC. This fund invests only in fixed-income markets. The fund invests primarily in senior secured loans. This includes floating-rate senior loans and high yield corporate bonds. It also holds credit instruments with different maturities that are issued to companies whose debt is usually below investment grade. It takes a conservative approach when selecting credit. This includes factors such as collateral coverage and structural seniority. The fund also focuses heavily on stable businesses with positive cash flows, leading market positions, solid management teams, and companies that have a proven track record. Apollo Tactical Income Fund Inc. is a U.S.-based company that was established on February 25, 2013.

Earnings per Share

Apollo Tactical Income Fund’s trailing 12 months EPS is $1.27.

PE Ratio

Apollo Tactical Income Fund’s trailing 12-month price-to-earnings ratio is 9.57. The purchaser of the shares is therefore investing $9.57 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity ratio, was negative at -10.88%.

Moving Average

Apollo Tactical Income Fund’s worth is under its 50-day moving average of $12.17 and under its 200-day moving average of $13.12.

Dividend Yield

According to Morningstar, Inc., there will be a next dividend payment on November 17, 2022. The forward dividend rate and forward dividend yield are respectively 1.38 and 11.08%.

Yearly Top and Bottom Value

Apollo Tactical Income Fund’s stock is valued at $12.15 at 09:15 EST, way below its 52-week high of $15.96 and higher than its 52-week low of $11.74.

More news about Apollo Tactical Income Fund.

2. SK Telecom (SKM) – Dividend Yield: 8.22%

SK Telecom’s last close was $20.85, 59.69% under its 52-week high of $51.73.

SK Telecom Co., Ltd. provides wireless telecommunication services in South Korea. The company operates through three segments: Cellular Services, Fixed-Line Telecommunications Services, and Other Businesses. The Cellular Services segment offers wireless voice and data transmission, Internet of Things solutions, platform, cloud, smart factory solutions, subscription, and metaverse platform-based services, as well as sells wireless devices. The Fixed-Line Telecommunications Services segment provides fixed-line telephone services; broadband Internet services; media platform services, such as Internet protocol TV and cable TV; and business communications services. The Other Businesses segment offers television shopping services under the T-commerce brand, as well as portal services. In addition, it provides call center management, base station maintenance, information gathering and consulting, system software development and supply, quantum information and communications, data base and internet website, and digital contents sourcing services; manufactures and sells e-book; sells contents and mastering quality sound album; sells and trades in anti-theft and surveillance devices; and operates information and communications facilities. As of December 31, 2021, the company had 3.6 million fixed-line telephone and 31.9 million wireless subscribers. SK Telecom Company Limited was incorporated in 1984 and is headquartered in Seoul, South Korea.

Earnings Per Share

As for profitability, SK Telecom has a trailing twelve months EPS of $2.03.

PE Ratio

SK Telecom has a trailing twelve months price to earnings ratio of 10.29. Meaning,
the purchaser of the share is investing $10.29 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.17%.

Yearly Top and Bottom Value

SK Telecom’s stock is valued at $20.85 at 09:16 EST, way below its 52-week high of $51.73 and way higher than its 52-week low of $18.32.

Revenue growth

The year-over-year revenue growth was 4%. For the 12 trailing months, 16.91T is now available.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

SK Telecom stock considered oversold (=20).

Moving Average

SK Telecom’s market value is greater than its 50-day moving mean of $19.89, and much lower than its 200-day moving mean of $23.48.

More news about SK Telecom.

3. Eaton Vance Risk (ETJ) – Dividend Yield: 8.18%

Eaton Vance Risk’s last close was $8.49, 25.53% under its 52-week high of $11.40.

Eaton Vance Risk Managed Diversified Equity Income fund is an equity mutual fund that has closed ends. It was launched by Eaton Vance Management. It invests in American public equity markets. The fund invests mainly in common stocks. It also purchases short-dated, out-of the-money S&P 500 Index put options. And it sells S&P 500 Index out-of the-money call options for the same period as put options that have roll dates that vary across the options portfolio. It invests in stock of companies that operate across diverse sectors. The fund benchmarks its portfolio performance against the S&P 500 Index as well as the Barclays U.S. Aggregate Bond Index. Eaton Vance Risk Managed Diversified Equity Income Fund was established on July 31, 2007, and is based in the United States.

Earnings Per Share

As for profitability, Eaton Vance Risk has a trailing twelve months EPS of $1.2.

PE Ratio

Eaton Vance Risk has a trailing twelve months price to earnings ratio of 7.07. Meaning,
the purchaser of the share is investing $7.07 for every dollar of annual earnings.

Yearly Top and Bottom Value

Eaton Vance Risk’s stock is valued at $8.49 at 09:17 EST, way below its 52-week high of $11.40 and above its 52-week low of $7.94.

Volume

Today’s last reported volume for Eaton Vance Risk is 127463 which is 14.92% below its average volume of 149832.

Moving Average

Eaton Vance Risk’s value is higher than its 50-day moving average of $8.46 and under its 200-day moving average of $9.14.

Volatility

The intraday variation average for Eaton Vance Risk in the last week, last year, and quarter was 0.12%, 0.28%, and 1.27 respectively.

The highest levels of volatility at Eaton Vance Risk were 0.64% (last Wednesday), 1.00%(last month), and 1.27 (last quarter).

More news about Eaton Vance Risk.

4. Nuveen California Dividend Advantage Municipal Fund (NAC) – Dividend Yield: 5.16%

Nuveen California Dividend Advantage Municipal Fund’s last close was $11.13, 29.33% under its 52-week high of $15.75.

Nuveen California Quality Municipal Income Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California, United States. The fund invests in undervalued municipal securities and other related investments that are exempt from regular federal and California income taxes. It primarily invests in securities that are rated Baa or BBB or better by Moody's Investors Service, Inc. or Standard & Poor's, and have an average maturity of 20.96 years. The fund employs fundamental analysis with a bottom-up approach to create its portfolio. It benchmarks the performance of its portfolio against the Standard & Poor's (S&P) California Municipal Bond Index and Standard & Poor's (S&P) National Municipal Bond Index. The fund was formerly known as Nuveen California Dividend Advantage Municipal Fund. Nuveen California Quality Municipal Income Fund was formed on December 1, 1998 and is domiciled in the United States.

Earnings Per Share

As for profitability, Nuveen California Dividend Advantage Municipal Fund has a trailing twelve months EPS of $0.38.

PE Ratio

Nuveen California Dividend Advantage Municipal Fund has a trailing twelve months price to earnings ratio of 29.52. Meaning,
the purchaser of the share is investing $29.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.2%.

More news about Nuveen California Dividend Advantage Municipal Fund.

5. Gilead Sciences (GILD) – Dividend Yield: 4.2%

Gilead Sciences’s last close was $86.26, 2.52% higher than its 52-week high of $84.14.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Earnings per Share

For profitability, Gilead Sciences’ trailing twelve-month EPS is $0.24

PE Ratio

Gilead Sciences’ trailing 12-month price-earnings ratio is 359.42. The purchaser of the shares is investing 359.42 dollars for each dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 20.58%.

Volume

Today’s last reported volume for Gilead Sciences is 3383960 which is 59.05% below its average volume of 8264600.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 101.4% while dropping 24.1% in the following.

Sales Growth

Gilead Sciences’s sales growth is negative 12.4% for the present quarter and negative 5.7% for the next.

More news about Gilead Sciences.

6. Phibro Animal Health Corporation (PAHC) – Dividend Yield: 3.43%

Phibro Animal Health Corporation’s last close was $13.98, 39.11% under its 52-week high of $22.96.

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Earnings per Share

For profitability, Phibro Animal Health Corporation’s trailing twelve-month EPS is $1.21

PE Ratio

The trailing 12-month price-earnings ratio for Phibro Animal Health Corporation is 11.55. The purchaser of the shares is thus investing $11.55 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 18.75%.

Earnings before Interest, Taxes and Depreciation

Phibro Animal Health Corporation has an EBITDA of 47.33.

Moving Average

Phibro Animal Health Corporation is worth less than its $50-day moving mean of $14.08, and much lower than its $200-day moving median of $17.96.

Dividend Yield

Morningstar, Inc. claims that the next dividend payment will be on Nov 28th 2022. The forward dividend rate for 2020 is 0.48, and the forward dividend yield for 2022 is 3.43%.

More news about Phibro Animal Health Corporation.

7. Internationa Flavors & Fragrances (IFF) – Dividend Yield: 3.38%

Internationa Flavors & Fragrances’s last close was $101.37, 33.27% under its 52-week high of $151.92.

International Flavors & Fragrances Inc. and its affiliates manufacture and sell cosmetic actives and natural ingredients that can be used in various consumer products throughout Europe, Africa and the Middle East. The company operates in the Nourish and Scent segments. Nourish offers natural, plant-based specialty foods ingredients such as flavors, savory options, and inclusions. Natural food protection ingredients include natural antioxidants, anti-microbials, as well as drinks, sweets, and dairy products. Scent provides fine perfumes including colognes and perfumes as well as fragrance components. It also offers fragrance ingredients which can be mixed with other materials to make fragrance or consumer compounds. Cosmetic active ingredients include active and functional ingredients as botanicals as well as delivery systems that support customers’ personal and cosmetic care products. Health & Biosciences produces and distributes enzymes, foods cultures, probiotics, specialty ingredients, as well as other special ingredients. Pharma Solutions produces cellulosics, and seaweed-based pharmaceutical excipients. It sells products to cosmetic and personal care product manufacturers, including soaps and shampoos, perfumes, skin care, hygiene products and cleaning products. International Flavors & Fragrances Inc. is a New York-based company that was established in 1833.

Earnings per Share

Internationa Flavors & Fragrances’ trailing 12-month EPS is $3.21.

PE Ratio

Internationa Flavors & Fragrances’ trailing 12-month price-to-earnings ratio is 31.58. The purchaser of the shares is making $31.58 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 3.05%.

Growth Estimates Quarters

For the current quarter, the company expects to grow by 7.8% for the first quarter and 1% the following.

Volume

Internationa Flavors & Fragrances’s latest reported volume is 489973, which is 72.03% lower than its average volume (1752220).

Moving Average

Internationa Flavors & Fragrances is worth more than its $50.71 moving average and much less than its $200.90 moving average.

Volatility

Internationa Flavors & Fragrances last week’s and last month’s intraday variations averages were 0.12%, 0.23% and 1.83% respectively.

Internationa Flavors & Fragrances had the highest amplitude average volatility at 0.49%, 1.61% and 1.83% respectively (last week),

More news about Internationa Flavors & Fragrances.

8. Pan American Silver Corp. (PAAS) – Dividend Yield: 2.66%

Pan American Silver Corp.’s last close was $14.59, 52.26% below its 52-week high of $30.56.

Pan American Silver Corp. and its affiliates engage in exploration, mining development, extraction and processing of copper, silver, zinc and lead mines in Canada and Mexico. Dolores and Morococha, Shahuindo and La Arena are its interests. Pan American Minerals Corp. was the company’s name before 1995. Pan American Silver Corp. became Pan American Silver Corp. Pan American Silver Corp. was founded in 1979. It is located in Vancouver, Canada.

Earnings Per Share

As for profitability, Pan American Silver Corp. has a trailing twelve months EPS of $0.85.

PE Ratio

Pan American Silver Corp. has a trailing twelve months price to earnings ratio of 17.23. Meaning,
the purchaser of the share is investing $17.23 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.42%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 18, 2022, the estimated forward annual dividend rate is 0.44 and the estimated forward annual dividend yield is 2.66%.

More news about Pan American Silver Corp..